New patent for Intra-cellular drug CAPLYTA – DrugPatentWatch
Copyright © DrugPatentWatch. Originally published at New patent for Intra-cellular drug CAPLYTA
Annual Drug Patent Expirations for CAPLYTA
Caplyta is a drug marketed by Intra-cellular and is included in one NDA. There are nine patents protecting this drug.
CAPLYTA drug price trends.
Drug patent…
Source: www.drugpatentwatch.com and Read More